Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide, in
part because of inadequate early detection strategies. Current recommendations for …

The most common primary liver cancer is hepatocellular carcinoma (HCC), and its mortality
rate is increasing globally. The overall 5-year survival of patients with liver cancer is …

Aberrant changes in site-specific core fucosylation (CF) of serum proteins contribute to
cancer development and progression, which enables them as potential diagnostic markers …

Death rates from primary liver cancer (hepatocellular carcinoma [HCC]) have continued to
rise in the United States over the recent decades despite the availability of an increasing …

Objective To investigate the role of serum alpha-fetoprotein (AFP) in diagnosing
subcentimeter hepatocellular carcinoma (HCC) on gadoxetic acid–enhanced MRI (EOB …

Background & Aims Hepatocellular carcinoma (HCC) surveillance is associated with
improved early detection and reduced mortality, although practice patterns and effectiveness …

Background The development of molecular targeted agents (MTAs) has changed the
treatment strategy for hepatocellular carcinoma (HCC). However, currently, there are no …

Circulating tumor cells (CTCs) detection presents significant advantages in diagnosing liver
cancer due to its noninvasiveness, real‐time monitoring, and dynamic tracking. However …

Hepatocellular carcinoma (HCC) diagnosis and management have undergone significant
improvements in recent years. With the introduction of immunotherapy-based combination …

Introduction Hepatocellular carcinoma (HCC) has a poor prognosis, related, in part, to
frequent late-stage diagnosis. Improved implementation of effective HCC surveillance is …